The Guardian reports that thousands more cancer patients in England will be offered vital treatments in a £160m boost to the Cancer Drugs Fund. The say that the fund, which has helped more than 55,000 cancer patients since it was set up four years ago, will be increased from £200m a year to £280m a year. As a result many more patients with rare conditions will benefit from life-extending drugs recommended by their doctor:
With the number of people diagnosed with cancer each year increasing by 9% since 2009, and the rising costs of ever more sophisticated drugs, the fund has an important role in helping patients receive treatment, enabling them to access drugs that are not routinely funded by the NHS.
Cancer experts at NHS England have also pinpointed two new drugs which will be added to the fund, a Department of Health spokeswoman said.
These are Xtandi (enzalutamide) for prostate cancer, and Revlimid (lenalidomide) for a new group of patients with myelodysplastic syndrome, a rare blood condition.
Meanwhile the Welsh Labour Government resists following suit leaving cancer patients here disadvantaged.
No comments:
Post a Comment
I am happy to address most contributions, even the drunken ones if they are coherent, but I am not going to engage with negative sniping from those who do not have the guts to add their names or a consistent on-line identity to their comments. Such postings will not be published.
Anonymous comments with a constructive contribution to make to the discussion, even if it is critical will continue to be posted. Libellous comments or remarks I think may be libellous will not be published.
I will also not tolerate personation so please do not add comments in the name of real people unless you are that person. If you do not like these rules then start your own blog.
Oh, and if you persist in repeating yourself despite the fact I have addressed your point I may get bored and reject your comment.
The views expressed in comments are those of the poster, not me.